Successful treatment of hyperglycemia with liraglutide in a hospitalized 27-year-old patient with schizophrenia: A case report

BACKGROUND: Antipsychotics are associated with abnormalities in glucose metabolism in patients with schizophrenia. Liraglutide, a GLP-1 receptor agonist, is Food and Drug Administration approved for the treatment of type 2 diabetes mellitus. However, ways to maintain the long-term stability of psych...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Lei, Yu, Wen-Juan, Zhu, Hui, Li, Hua-Fang, Qiao, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353915/
https://www.ncbi.nlm.nih.gov/pubmed/36158023
http://dx.doi.org/10.12998/wjcc.v10.i21.7495

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353915/
https://www.ncbi.nlm.nih.gov/pubmed/36158023
http://dx.doi.org/10.12998/wjcc.v10.i21.7495

Ejemplares similares